百花医药
(600721)
| 流通市值:30.49亿 | | | 总市值:30.49亿 |
| 流通股本:3.85亿 | | | 总股本:3.85亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 230,543,932.05 | 157,357,180.82 | 67,182,856.85 | 388,319,392.98 |
| 营业总成本 | 197,620,083.89 | 129,665,410.33 | 55,423,758.66 | 310,478,518.94 |
| 其他经营收益 | | | | |
| 营业利润 | 19,232,285.37 | 16,584,474.83 | 7,290,434.57 | 44,244,477.86 |
| 利润总额 | 19,295,160.78 | 16,717,956.19 | 7,263,417.82 | 44,161,885.27 |
| 净利润 | 16,819,736.69 | 14,760,272.46 | 6,642,724.56 | 40,687,937.25 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | 40,319.46 |
| 综合收益总额 | 16,819,736.69 | 14,760,272.46 | 6,642,724.56 | 40,728,256.71 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 545,020,864.73 | 523,698,484.4 | 556,291,882.1 | 565,414,570.53 |
| 非流动资产: | | | | |
| 非流动资产合计 | 537,330,101.97 | 541,435,606.46 | 536,914,885.05 | 532,155,763.19 |
| 资产总计 | 1,082,350,966.7 | 1,065,134,090.86 | 1,093,206,767.15 | 1,097,570,333.72 |
| 流动负债: | | | | |
| 流动负债合计 | 229,674,174.63 | 215,069,368.13 | 235,460,885.49 | 246,843,599.68 |
| 非流动负债: | | | | |
| 非流动负债合计 | 49,988,310.44 | 49,403,385.4 | 49,265,128.58 | 48,888,705.52 |
| 负债合计 | 279,662,485.07 | 264,472,753.53 | 284,726,014.07 | 295,732,305.2 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 802,688,481.63 | 800,661,337.33 | 808,480,753.08 | 801,838,028.52 |
| 股东权益合计 | 802,688,481.63 | 800,661,337.33 | 808,480,753.08 | 801,838,028.52 |
| 负债和股东权益合计 | 1,082,350,966.7 | 1,065,134,090.86 | 1,093,206,767.15 | 1,097,570,333.72 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 216,576,454.72 | 131,484,975.41 | 61,008,490.84 | 342,224,636.44 |
| 经营活动现金流出小计 | 196,269,013.53 | 132,497,014.7 | 70,645,085.33 | 311,806,072.01 |
| 经营活动产生的现金流量净额 | 20,307,441.19 | -1,012,039.29 | -9,636,594.49 | 30,418,564.43 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,041,022,187.97 | 692,208,708.7 | 243,259,643.79 | 887,240,547.73 |
| 投资活动现金流出小计 | 1,282,138,514.72 | 905,836,697.69 | 483,817,093.06 | 906,445,051.66 |
| 投资活动产生的现金流量净额 | -241,116,326.75 | -213,627,988.99 | -240,557,449.27 | -19,204,503.93 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 20,000,000 | 20,000,000 | 20,000,000 | 2,564,700 |
| 筹资活动现金流出小计 | 35,461,693.18 | 35,461,693.18 | 79,787.78 | - |
| 筹资活动产生的现金流量净额 | -15,461,693.18 | -15,461,693.18 | 19,920,212.22 | 2,564,700 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -236,270,578.74 | -230,101,721.46 | -230,273,831.54 | 13,778,760.5 |
| 期末现金及现金等价物余额 | 49,556,310.01 | 55,725,167.29 | 55,553,057.21 | 285,826,888.75 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -230,101,721.46 | - | 13,778,760.5 |